DK158724C - Analogifremgangsmaade til fremstilling af 5-phenylhydantoinderivater eller farmaceutisk acceptable salte deraf - Google Patents
Analogifremgangsmaade til fremstilling af 5-phenylhydantoinderivater eller farmaceutisk acceptable salte derafInfo
- Publication number
- DK158724C DK158724C DK499983A DK499983A DK158724C DK 158724 C DK158724 C DK 158724C DK 499983 A DK499983 A DK 499983A DK 499983 A DK499983 A DK 499983A DK 158724 C DK158724 C DK 158724C
- Authority
- DK
- Denmark
- Prior art keywords
- analogue
- phenyl
- preparation
- acceptable salts
- pharmaceutical acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/438,199 US4452806A (en) | 1982-11-01 | 1982-11-01 | Treating diabetic complications with 5-(substituted phenyl)hydantoins |
| US43819982 | 1982-11-01 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK499983D0 DK499983D0 (da) | 1983-11-01 |
| DK499983A DK499983A (da) | 1984-05-02 |
| DK158724B DK158724B (da) | 1990-07-09 |
| DK158724C true DK158724C (da) | 1990-11-19 |
Family
ID=23739660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK499983A DK158724C (da) | 1982-11-01 | 1983-11-01 | Analogifremgangsmaade til fremstilling af 5-phenylhydantoinderivater eller farmaceutisk acceptable salte deraf |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4452806A (da) |
| JP (1) | JPS5998063A (da) |
| KR (1) | KR860001507B1 (da) |
| CA (1) | CA1203241A (da) |
| DK (1) | DK158724C (da) |
| ES (1) | ES8507119A1 (da) |
| FI (1) | FI80265C (da) |
| GR (1) | GR79638B (da) |
| HU (1) | HU191887B (da) |
| PL (1) | PL139646B1 (da) |
| PT (1) | PT77578A (da) |
| YU (1) | YU43556B (da) |
| ZA (1) | ZA838092B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1321980A4 (en) | 2000-09-25 | 2007-04-04 | Ibiden Co Ltd | SEMICONDUCTOR ELEMENT, METHOD FOR MANUFACTURING SEMICONDUCTOR ELEMENT, MULTILAYER PRINTED CIRCUIT BOARD, AND METHOD FOR MANUFACTURING MULTILAYER PRINTED CIRCUIT BOARD |
| IT1319201B1 (it) * | 2000-10-12 | 2003-09-26 | Nicox Sa | Farmaci per il diabete. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4189587A (en) * | 1977-04-05 | 1980-02-19 | Ciba-Geigy Corporation | 1,3-Diaminomethyl-hydantoin additives for lubricating oils |
| FR2458546A1 (fr) * | 1979-06-07 | 1981-01-02 | Hoechst France | Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant |
-
1982
- 1982-11-01 US US06/438,199 patent/US4452806A/en not_active Expired - Fee Related
-
1983
- 1983-10-26 GR GR72794A patent/GR79638B/el unknown
- 1983-10-28 PL PL1983244350A patent/PL139646B1/pl unknown
- 1983-10-28 PT PT77578A patent/PT77578A/pt not_active IP Right Cessation
- 1983-10-28 ES ES526841A patent/ES8507119A1/es not_active Expired
- 1983-10-31 FI FI833993A patent/FI80265C/fi not_active IP Right Cessation
- 1983-10-31 HU HU833734A patent/HU191887B/hu not_active IP Right Cessation
- 1983-10-31 KR KR1019830005157A patent/KR860001507B1/ko not_active IP Right Cessation
- 1983-10-31 CA CA000440069A patent/CA1203241A/en not_active Expired
- 1983-10-31 ZA ZA838092A patent/ZA838092B/xx unknown
- 1983-10-31 YU YU2167/83A patent/YU43556B/xx unknown
- 1983-11-01 JP JP58205707A patent/JPS5998063A/ja active Granted
- 1983-11-01 DK DK499983A patent/DK158724C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI833993A0 (fi) | 1983-10-31 |
| JPH0465832B2 (da) | 1992-10-21 |
| DK499983A (da) | 1984-05-02 |
| PT77578A (en) | 1983-11-01 |
| HU191887B (en) | 1987-04-28 |
| FI80265C (fi) | 1990-05-10 |
| PL244350A1 (en) | 1985-02-13 |
| FI80265B (fi) | 1990-01-31 |
| KR840006630A (ko) | 1984-12-01 |
| PL139646B1 (en) | 1987-02-28 |
| ES526841A0 (es) | 1985-05-01 |
| ZA838092B (en) | 1985-06-26 |
| JPS5998063A (ja) | 1984-06-06 |
| CA1203241A (en) | 1986-04-15 |
| DK158724B (da) | 1990-07-09 |
| US4452806A (en) | 1984-06-05 |
| KR860001507B1 (ko) | 1986-09-30 |
| DK499983D0 (da) | 1983-11-01 |
| FI833993A (fi) | 1984-05-02 |
| YU216783A (en) | 1986-02-28 |
| YU43556B (en) | 1989-08-31 |
| GR79638B (da) | 1984-10-31 |
| ES8507119A1 (es) | 1985-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK161770C (da) | Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf | |
| DK160940C (da) | Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf | |
| DK149449C (da) | Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf | |
| DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
| DK163359C (da) | Analogifremgangsmaade til fremstilling af n-imidazolylderivater af bicycliske forbindelser eller pharmaceutisk acceptable salte deraf | |
| DK163244C (da) | Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf | |
| DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
| DK161968C (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
| DK158269C (da) | Analogifremgangsmaade til fremstilling af morpholinyldaunorubicin- eller morpholinyldoxorubicinderivater | |
| DK148537C (da) | Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf | |
| DK158306C (da) | Analogifremgangsmaade til fremstilling af substituerede pyridylallylforbindelser eller farmaceutisk acceptable salte deraf | |
| DK162166C (da) | Analogifremgangsmaade til fremstilling af (2s)-isomere af 2-oe4-(2-hydroxycyclopentan-1-ylmethyl)phenylaapropionsyre eller farmaceutisk acceptable salte deraf | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK161699C (da) | Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf | |
| DK155670C (da) | Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf | |
| DK149269C (da) | Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf | |
| DK413883D0 (da) | Fremgangsmade til fremstilling af c-20-modificerede macrolid-derivater eller farmaceutisk acceptable salte deraf | |
| DK165005C (da) | Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf | |
| DK149093C (da) | Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf | |
| DK158227C (da) | Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf | |
| DK162102C (da) | Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf | |
| DK152491C (da) | Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf | |
| DK148019C (da) | Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf | |
| DK150521C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf | |
| DK151254C (da) | Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |